002412SZSE

Announcement on the Resolutions of the Eleventh Meeting of the Sixth Board of Directors

✨ AI Summary

The Board of Directors of Hunan Hansen Pharmaceutical Co., Ltd. held its eleventh meeting, approving the 2025 annual reports, financial statements, and profit distribution plan. Key decisions include a cash dividend of RMB 3 per 10 shares and authorizing the management to apply for bank loans up to RMB 500 million in 2026. The meeting also addressed the election of the seventh board of directors and the reappointment of the auditor.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Securities Code: 002412 Securities Abbreviation: Hansen Pharmaceutical Announcement No.: 2026-001 Hunan Hansen Pharmaceutical Co., Ltd. Announcement on the Resolutions of the Eleventh Meeting of the Sixth Board of Directors The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

I. Convening of the Board Meeting

The Eleventh Meeting of the Sixth Board of Directors of Hunan Hansen Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held in the first-floor conference room of the Company on April 24, 2026, in a face-to-face format. The meeting was convened and presided over by Mr. Liu Zhengqing, Chairman of the Board. The meeting notice was delivered to all directors and senior management personnel on April 13, 2026, via hand delivery, fax, and email. A total of 8 directors were eligible to attend, and 8 directors actually attended. Senior management personnel of the Company attended the meeting. The convening and holding of this meeting comply with the "Company Law of the People's Republic of China" and the "Articles of Association" of the Company.

II. Deliberations of the Board Meeting

(I) Approved the "2025 President's Work Report" Voting results: 8 votes in favor; 0 votes against; 0 votes abstained.

(II) Approved the "2025 Board of Directors' Work Report" The full text of the "2025 Board of Directors' Work Report" can be found on the Company's designated information disclosure website, Eastmoney (www.cninfo.com.cn). Independent directors submitted their annual work reports to the Board and will present them at the Company's 2025 Annual General Meeting. The full text of the "Independent Directors' 2025 Annual Work Reports" can be found on Eastmoney (www.cninfo.com.cn) on the same day. This proposal needs to be submitted for deliberation at the 2025 Annual General Meeting. Voting results: 8 votes in favor; 0 votes against; 0 votes abstained.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Announcement on the Resolutions of the Eleventh Meeting of the Sixth Board of Directors — Hansen Pharmaceuticals Co., Ltd. | SZSE Releases